As women approach perimenopause, the transitional phase before menopause, they often experience a constellation of symptoms including fatigue, decreased libido, mood changes, and difficulty maintaining muscle mass. While estrogen and progesterone typically dominate conversations about menopausal hormone therapy, emerging research suggests testosterone may play a significant role in managing certain perimenopausal symptoms.
Testosterone, often considered a male hormone, is naturally produced in women’s ovaries and adrenal glands, though in much smaller quantities than in men. During perimenopause, testosterone levels can decline by up to 50%, contributing to symptoms that significantly impact quality of life. Recent clinical studies have shown that testosterone therapy may effectively address low sexual desire, one of the most common complaints during this transition. The Endocrine Society recognizes testosterone treatment for hypoactive sexual desire disorder in postmenopausal women, though evidence for perimenopausal use continues to evolve.
Beyond libido, preliminary research indicates potential benefits for energy levels, muscle strength, and bone density. A 2023 systematic review found that women receiving testosterone supplementation alongside traditional hormone replacement therapy reported improved vitality and reduced fatigue compared to those on estrogen-progesterone therapy alone. Additionally, testosterone’s role in maintaining lean muscle mass may help counter the metabolic changes that often accompany perimenopause, including increased abdominal fat and decreased metabolic rate.
However, medical experts urge caution. Testosterone therapy is not FDA-approved specifically for perimenopausal symptoms, and potential side effects include acne, hair growth, voice deepening, and cardiovascular concerns when used improperly. Dr. Sarah Mitchell, an endocrinologist at Boston Medical Center, emphasizes that “testosterone should only be considered after comprehensive evaluation and when other treatments have been inadequate. Proper dosing and monitoring are essential to minimize risks.”
Women experiencing perimenopausal symptoms should consult healthcare providers specializing in hormone health to determine whether testosterone therapy is appropriate for their individual circumstances. As research continues, the medical community is gaining a more nuanced understanding of how this hormone may contribute to comprehensive perimenopause management.
